Multidrug-resistant tuberculosis in the USA: the end of the beginning.
Nolan
C M
CM
D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D002939:Ciprofloxacin / Q000627:therapeutic use; D006282:Health Personnel; D006801:Humans; D011718:Pyrazinamide / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000517:prevention & control*; D014481:United States
D000995:Antitubercular Agents; D001500:BCG Vaccine; D011718:Pyrazinamide; D002939:Ciprofloxacin